Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/26/1999US5972621 Incubating a cell that expresses an obr protein encoded by an exogenous nucleic acid molecule in the presence and absence of a test compound; determining phosphorylation, identifying compounds that alter phosphorylation; obesity, cachexia
10/26/1999US5972609 Utrophin gene promotor
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972598 Methods for preventing multidrug resistance in cancer cells
10/26/1999US5972370 Peptide/protein suspending formulations
10/26/1999US5972369 Includes reservoir comprising beneficial agent and capillary channel in communication with reservoir and exterior of system for delivering beneficial agent from system
10/26/1999US5972365 Remedy for prurigo
10/26/1999US5972353 Immunogenic amount of an immunologically active mn protein or m polypeptide effective to immunize a vertebrate against a neoplastic disease associated with expression of mn antigen
10/26/1999US5972352 Cloning of mite allergens
10/26/1999US5972348 Nickel binding protein and its encoding dna isolated from helicobacter pylori; useful as vaccine, diagnostic, drug target, and therapy in itself
10/26/1999US5972339 Method of eliciting anti-HIV-1 helper T cell responses
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972336 Urease-based vaccine against helicobacter infection
10/26/1999US5972335 Compositions for promoting the healing of wounds or fibrotic disorders comprising at least one agent specific to either a growth factor or a protein associated therewith; antibodies
10/26/1999US5972333 Synthetic mammalian sulphamidase and genetic sequences encoding same
10/26/1999US5972332 Enhancing the healing of wounds, especially chronic wounds (e.g., diabetic wounds), are provided involving the use of keratinocytes
10/26/1999US5972331 Crystalline interferon alpha for pulmonary delivery and method for producing the same
10/26/1999US5972317 Nail-permeable medication means is disclosed for delivering a medicament through nails, claws, hoofs, or other similar hardened tissue of dermal derivation; includes proteolytic enzyme and drug selected to treat specific disease
10/26/1999US5972311 Method of preventing dental caries and other oral lesions
10/26/1999US5972308 Reacting technetium-99 with a cyclic oligopeptide having amino acid units containing a mercaptan group attached to the ring through a homocysteine unit.
10/26/1999US5970985 Use of hemoglobin to treat systemic inflammatory response syndrome
10/26/1999US5970973 Method of delivering insulin lispro
10/26/1999CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/26/1999CA2057536C Cloning and expression of borrelia lipoproteins
10/26/1999CA2029678C Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14
10/26/1999CA1340805C Nucleotide sequence incoding plant ribosome inactivating protein
10/24/1999CA2269397A1 A nutrition-enriched composition for feed, and feed
10/21/1999WO1999053091A2 Dna coding for gdnf, parts of said dna and gdnf variants
10/21/1999WO1999053078A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053066A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999WO1999053064A2 Methods of delivering glp-1
10/21/1999WO1999053063A1 PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV1 RETROVIRUS p24 PROTEIN
10/21/1999WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999WO1999053057A1 Protein and gene participating in the differentiation of immortalized cells
10/21/1999WO1999053056A1 Novel protein and processes for producing the same
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999053053A1 Gene coding for heliomicine and use thereof
10/21/1999WO1999053045A1 Secreted proteins and polynucleotides encoding them
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053042A2 Biological material with increased expression of endogenous complement regulatory molecules
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053038A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999053029A1 Method and system for managing batches of lymphocytes or monocytes for delayed use
10/21/1999WO1999053027A1 Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999053026A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
10/21/1999WO1999053022A2 Selection of lineage specific cells after differentiation of progenitor cells
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052946A1 Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses
10/21/1999WO1999052945A2 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
10/21/1999WO1999052944A1 G-protein coupled receptors
10/21/1999WO1999052940A1 Method for extracting, identifying, using active principles of marine mollusque shells
10/21/1999WO1999052939A1 Peptides
10/21/1999WO1999052936A2 Arginine peptide analogs useful as fibroblast growth factor antagonists
10/21/1999WO1999052935A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999WO1999052928A1 Transporter protein splice variants and model for immune diversity
10/21/1999WO1999052925A1 Programmed cell death and caspase-12
10/21/1999WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999WO1999052858A2 Lipids
10/21/1999WO1999052572A1 Methods and compositions for tissue regeneration
10/21/1999WO1999052562A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999052548A2 Conjugate vaccines for the prevention of dental caries
10/21/1999WO1999052547A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
10/21/1999WO1999052545A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
10/21/1999WO1999052544A2 Regulation of ovarian maturation and function using epidermal growth factor
10/21/1999WO1999052543A2 Pharmaceutical compositions comprising erythropoietin for treatment of cancer
10/21/1999WO1999052542A1 Use of erythropoietin for the treatment of haemochromatoses
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052540A1 Methods for treatment and prevention of infections
10/21/1999WO1999052539A1 Neo-tryptophan
10/21/1999WO1999052537A1 Anti-bacterial protein extracts from seeds of marigold and paprika
10/21/1999WO1999052523A2 Flutamide compositions and preparations
10/21/1999WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999WO1999052512A1 Coated starch capsules and a process for producing them
10/21/1999WO1999052507A1 Incorporation of active substances in carrier matrixes
10/21/1999WO1999052415A2 Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor
10/21/1999WO1999046386B1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999046298A3 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
10/21/1999WO1999045894A3 Cosmetic compositions
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042577A3 Biotin-binding receptor molecules
10/21/1999WO1999042137A3 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999040113A9 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
10/21/1999WO1999038992A9 Synergism between thymidine kinase gene therapy and topoisomerase i and topoisomerase ii inhibitors
10/21/1999WO1999038501A9 Method of regulating glucose metabolism, and reagents related thereto
10/21/1999WO1999036530A3 Lh-receptor gene promoter for tissue-specific gene expression
10/21/1999WO1999036529A3 Twik-1 related two p domains potassium channel
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999032643A3 Mood disorder gene
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999WO1999029279A3 Long-term survival and regeneration of central nervous system neurons
1 ... 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 ... 3163